Dave McCollum | Sutro Biopharma, Inc.

Sutro Marks Two Drug Development Milestones

Sutro Marks Two Drug Development Milestones Receives Celgene Payment, Completes Production for Clinical Trials of Internally-Developed ADC SOUTH SAN FRANCISCO, Oct. 11, 2017 — Sutro Biopharma has received a manufacturing milestone payment from Celgene and has...

Sutro & Celgene to Refocus 2014 Immuno-Oncology Collaboration on Four Programs

Press Releases

Sutro & Celgene to Refocus 2014 Immuno-Oncology Collaboration on Four Programs Will Rapidly Advance Promising Drug Candidates to the Clinic SOUTH SAN FRANCISCO, Aug. 10, 2017 – Sutro Biopharma today announced it is refocusing its 2014 immuno-oncology...